The week in health tech, explained in plain English.Get the free newsletter →
November 10, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Finance

Healthcare AI Moves From Pilots to Closing the Revenue Gap

Healthcare organizations are graduating from early AI experiments to wider adoption, and the clearest payoff is showing up in the revenue cycle, according to Healthcare Dive. After years of small, contained pilots, more systems are connecting clinical improvements to measurable financial results.

In practice, that means pointing AI at the administrative work that quietly drains margins: medical coding, clinical documentation, claims submission, and denial management. These are repetitive, high-volume tasks where errors and delays translate directly into lost or postponed revenue. By automating and improving accuracy across these steps, organizations aim to capture money they were already entitled to but failing to collect.

The broader takeaway for executives is that AI's business case in healthcare is shifting from clinical promise to financial proof. Operators want tools that demonstrate return, not just potential. As reimbursement pressure and labor shortages persist, revenue cycle automation has become one of the most defensible places to invest, and a likely proving ground for how AI scales across the rest of the enterprise.

More in Finance

Finance

Novartis Lp(a) Drug Lowers Risk Marker but Fails on Outcomes

Novartis's pelacarsen lowered the cardiovascular risk marker Lp(a) but failed to reduce heart attacks or strokes, undermining a major industry strategy.

Why it matters: A failed outcomes trial for a leading Lp(a) drug threatens billions in cardiovascular research built on the assumption that lowering the marker prevents events.

Finance

Novo's Ziltivekimab Flops, But Cardiologists Stay Bullish

Novo Nordisk's ziltivekimab missed in the ZEUS cardiovascular trial, but cardiologists say the anti-inflammatory approach to heart disease remains valid.

Why it matters: Anti-inflammatory therapy is one of the biggest bets in cardiovascular medicine, and how the field reacts to a high-profile failure shapes billions in future R&D.

Finance

Pennsylvania Revokes Sharon Regional Hospital License

Pennsylvania revoked Sharon Regional Medical Center's license and ordered it to close after its utility moved to cut power over an unpaid bill.

Why it matters: An unpaid electricity bill forcing a hospital's closure shows how severe financial distress can abruptly cut off care for an entire community.